Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$27.66 USD
+0.13 (0.47%)
Updated May 14, 2024 04:00 PM ET
After-Market: $27.71 +0.05 (0.18%) 6:34 PM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 0.22 |
EPS Last Quarter | 0.25 |
Last EPS Surprise | 19.05% |
ABR | 1.00 |
Earnings ESP
|
6.06% |
---|---|
Current Year | 0.97 |
Next Year | 1.40 |
EPS (TTM) | 1.06 |
P/E (F1) | 28.31 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 152.75M | 159.63M | 623.44M | 643.80M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 158.30M | 163.80M | 640.80M | 708.00M |
Low Estimate | 147.62M | 157.34M | 609.12M | 556.33M |
Year ago Sales | 117.72M | 123.60M | 482.38M | 623.44M |
Year over Year Growth Est. | 29.76% | 29.15% | 29.24% | 3.27% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.22 | 0.22 | 0.97 | 1.40 |
# of Estimates | 4 | 4 | 4 | 5 |
Most Recent Consensus | 0.21 | 0.22 | 0.95 | 1.40 |
High Estimate | 0.28 | 0.29 | 1.11 | 1.81 |
Low Estimate | 0.18 | 0.11 | 0.86 | 1.14 |
Year ago EPS | 0.25 | 0.28 | 0.94 | 0.97 |
Year over Year Growth Est. | -12.00% | -21.43% | 3.19% | 44.48% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.22 | 0.22 | 0.97 | 1.40 |
7 Days Ago | 0.22 | 0.22 | 0.97 | 1.40 |
30 Days Ago | 0.24 | 0.23 | 0.99 | 1.32 |
60 Days Ago | 0.24 | 0.23 | 0.99 | 1.30 |
90 Days Ago | 0.16 | 0.14 | 0.81 | 1.02 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.23 | 0.25 | 0.93 | 1.39 |
Zacks Consensus Estimate | 0.22 | 0.22 | 0.97 | 1.40 |
Earnings ESP | 6.06% | 16.28% | -4.71% | -1.35% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.25 | 0.28 | 0.28 | 0.25 | NA |
Estimate | 0.21 | 0.25 | 0.22 | 0.15 | NA |
Difference | 0.04 | 0.03 | 0.06 | 0.10 | 0.06 |
Surprise | 19.05% | 12.00% | 27.27% | 66.67% | 31.25% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more